Raymond James & Associates Has $2.13 Million Stock Position in Cabot Co. (NYSE:CBT)

Raymond James & Associates increased its stake in shares of Cabot Co. (NYSE:CBTGet Rating) by 13.6% during the 3rd quarter, Holdings Channel reports. The institutional investor owned 33,326 shares of the specialty chemicals company’s stock after buying an additional 3,977 shares during the period. Raymond James & Associates’ holdings in Cabot were worth $2,129,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Moody Lynn & Lieberson LLC raised its holdings in Cabot by 295.5% during the 2nd quarter. Moody Lynn & Lieberson LLC now owns 59,320 shares of the specialty chemicals company’s stock worth $3,784,000 after purchasing an additional 44,320 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. raised its holdings in Cabot by 0.5% during the 2nd quarter. Mirae Asset Global Investments Co. Ltd. now owns 272,040 shares of the specialty chemicals company’s stock worth $17,354,000 after purchasing an additional 1,482 shares during the last quarter. Symphony Financial Ltd. Co. bought a new stake in Cabot during the 2nd quarter worth about $670,000. Hancock Whitney Corp raised its holdings in Cabot by 4.2% during the 2nd quarter. Hancock Whitney Corp now owns 56,959 shares of the specialty chemicals company’s stock worth $3,633,000 after purchasing an additional 2,317 shares during the last quarter. Finally, Paradiem LLC bought a new stake in Cabot during the 3rd quarter worth about $2,985,000. 94.21% of the stock is owned by institutional investors.

Cabot Stock Performance

Shares of CBT stock opened at $72.33 on Monday. The company has a debt-to-equity ratio of 1.06, a current ratio of 1.65 and a quick ratio of 1.05. The stock has a market cap of $4.07 billion, a PE ratio of 20.09 and a beta of 1.38. The stock has a 50-day moving average of $70.55 and a 200-day moving average of $70.29. Cabot Co. has a one year low of $53.32 and a one year high of $78.62.

Cabot (NYSE:CBTGet Rating) last announced its quarterly earnings results on Monday, November 7th. The specialty chemicals company reported $1.55 EPS for the quarter, beating analysts’ consensus estimates of $1.48 by $0.07. Cabot had a return on equity of 35.30% and a net margin of 4.84%. The company had revenue of $1.11 billion during the quarter, compared to analysts’ expectations of $1.04 billion. As a group, sell-side analysts expect that Cabot Co. will post 6.5 earnings per share for the current year.

Cabot Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, March 10th. Investors of record on Friday, February 24th will be paid a dividend of $0.37 per share. The ex-dividend date is Thursday, February 23rd. This represents a $1.48 dividend on an annualized basis and a yield of 2.05%. Cabot’s payout ratio is 41.11%.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on CBT. StockNews.com raised Cabot from a “buy” rating to a “strong-buy” rating in a report on Friday. Deutsche Bank Aktiengesellschaft raised Cabot from a “hold” rating to a “buy” rating and upped their price target for the company from $80.00 to $90.00 in a research note on Wednesday, November 16th.

Cabot Company Profile

(Get Rating)

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.

Further Reading

Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Co. (NYSE:CBTGet Rating).

Institutional Ownership by Quarter for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.